An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease von Rieder, F., Bettenworth, D., Ma, C., Parker, C. E., Williamson, L. A., Nelson, S. A., van Assche, G., Di Sabatino, A., Bouhnik, Y., Stidham, R. W., Dignass, A., Rogler, G., Taylor, S. A., Stoker, J., Rimola, J., Baker, M. E., Fletcher, J. G., Panes, J., Sandborn, W. J., Feagan, B. G., Jairath, V.

Volltext

Laboratory markers in IBD: useful, magic, or unnecessary toys? von Vermeire, S, Van Assche, G, Rutgeerts, P

Volltext

Short‐ and medium‐term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres von de Buck van Overstraeten, A., Eshuis, E. J., Vermeire, S., Van Assche, G., Ferrante, M., D'Haens, G. R., Ponsioen, C. Y., Belmans, A., Buskens, C. J., Wolthuis, A. M., Bemelman, W. A., D'Hoore, A.

Volltext

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management von Dignass, A., Van Assche, G., Lindsay, J.O., Lémann, M., Söderholm, J., Colombel, J.F., Danese, S., D'Hoore, A., Gassull, M., Gomollón, F., Hommes, D.W., Michetti, P., O'Morain, C., Öresland, T., Windsor, A., Stange, E.F., Travis, S.P.L.

Volltext

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study von Fidder, H, Schnitzler, F, Ferrante, M, Noman, M, Katsanos, K, Segaert, S, Henckaerts, L, Van Assche, G, Vermeire, S, Rutgeerts, P

Volltext

Review article: infliximab therapy for inflammatory bowel disease – seven years on von RUTGEERTS, P., ASSCHE, G., VERMEIRE, S.

Volltext

Anti‐infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response von Dreesen, E., Van Stappen, T., Ballet, V., Peeters, M., Compernolle, G., Tops, S., Van Steen, K., Van Assche, G., Ferrante, M., Vermeire, S., Gils, A.

Volltext

Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines von Panes, J., Bouhnik, Y., Reinisch, W., Stoker, J., Taylor, S.A., Baumgart, D.C., Danese, S., Halligan, S., Marincek, B., Matos, C., Peyrin-Biroulet, L., Rimola, J., Rogler, G., van Assche, G., Ardizzone, S., Ba-Ssalamah, A., Bali, M.A., Bellini, D., Biancone, L., Castiglione, F., Ehehalt, R., Grassi, R., Kucharzik, T., Maccioni, F., Maconi, G., Magro, F., Martín-Comín, J., Morana, G., Pendsé, D., Sebastian, S., Signore, A., Tolan, D., Tielbeek, J.A., Weishaupt, D., Wiarda, B., Laghi, A.

Volltext

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis von Arijs, I, Li, K, Toedter, G, Quintens, R, Van Lommel, L, Van Steen, K, Leemans, P, De Hertogh, G, Lemaire, K, Ferrante, M, Schnitzler, F, Thorrez, L, Ma, K, Song, X-Y R, Marano, C, Van Assche, G, Vermeire, S, Geboes, K, Schuit, F, Baribaud, F, Rutgeerts, P

Volltext

Quantum distribution of Gaussian keys using squeezed states von Cerf, N. J., Lévy, M., Assche, G. Van

Volltext

Dose de‐escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease – a nested case–control study von Van Steenbergen, S., Bian, S., Vermeire, S., Van Assche, G., Gils, A., Ferrante, M.

Volltext

Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis von Baert, F., Vande Casteele, N., Tops, S., Noman, M., Van Assche, G., Rutgeerts, P., Gils, A., Vermeire, S., Ferrante, M.

Volltext

Review article: altering the natural history of Crohn's disease – evidence for and against current therapies von VERMEIRE, S., VAN ASSCHE, G., RUTGEERTS, P.

Volltext

Reaction mechanism, kinetics and high temperature transformations of geopolymers von Rahier, H., Wastiels, J., Biesemans, M., Willlem, R., Van Assche, G., Van Mele, B.

Volltext

Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis von Colombel, J.‐F., Sandborn, W. J., Reinisch, W., Peyrin‐Biroulet, L., Panaccione, R., Rutgeerts, P., Hanauer, S. B., Ghosh, S., Van Assche, G., Robinson, A. M., Lau, W., Maa, J.‐F., Huang, B., Pappalardo, B., Read, H.

Volltext

Management of acute severe ulcerative colitis von Van Assche, Gert, Vermeire, Séverine, Rutgeerts, Paul

Volltext

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease von Rahier, J F, Ben-Horin, S, Chowers, Y, Conlon, C, De Munter, P, D'Haens, G, Domènech, E, Eliakim, R, Eser, A, Frater, J, Gassull, M, Giladi, M, Kaser, A, Lémann, M, Moreels, T, Moschen, A, Pollok, R, Reinisch, W, Schunter, M, Stange, E F, Tilg, H, Van Assche, G, Viget, N, Vucelic, B, Walsh, A, Weiss, G, Yazdanpanah, Y, Zabana, Y, Travis, S P L, Colombel, J F

Volltext

Isothermal structure development in submicron P3HT layers studied by fast scanning chip calorimetry von Van den Brande, N., Van Assche, G., Van Mele, B.

Volltext

SECM study of defect repair in self-healing polymer coatings on metals von González-García, Y., Mol, J.M.C, Muselle, T., De Graeve, I., Van Assche, G., Scheltjens, G., Van Mele, B., Terryn, H.

Volltext

Outcome of restorative proctocolectomy with an ileo‐anal pouch for ulcerative colitis: effect of changes in clinical practice von Germain, A., Buck van Overstraeten, A., Wolthuis, A., Ferrante, M., Vermeire, S., Van Assche, G., D'Hoore, A.

Volltext